Track topics on Twitter Track topics that are important to you
ChondroGene was formed in 1998 with the bringing together of its two key founders; Dr. K. Wayne Marshall, a noted orthopaedic surgeon and knee specialist and Dr. C.C. Liew, an internationally recognized leader in the area of tissue-specific functional genomics. Their respective expertise was combined to focus on developing new drugs and tests for osteoarthritis (OA), a chronic condition which affects the joints of millions of individuals worldwide, resulting in diminished quality of life for patients and severe economic burdens on healthcare systems.
The Company initially focussed on the use of functional genomics to characterize the molecular activity in tissues that make up the joints in the human body - cartilage, synovium and synovial fluid. The goal was to examine how the tissues of the joint function in different stages of osteoarthritis; from normal joints, to moderately diseased joints, all the way to severe osteoarthritis which could only be treated by total joint replacement. This work culminated in 2001 with the substantial completion of the identification and characterization of the chondrocyte genome (genes expressed in healthy and diseased human cartilage cells). The Company then produced the first known cDNA microarray specifically targeted at human cartilage gene expression, the ChondroChip™, an important platform tool that the Company is using to advance its research efforts in osteoarthritis. At the same time, the Company has applied the Sentinel Principle, a blood-based biomarker approach originally developed by Dr. Liew, to measure RNA expression in blood that can be used to detect and diagnose a variety of diseases and medical conditions throughout the body.
800 Petrolia Road, Unit 15
JERSEY, Channel Islands, May 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive O...
CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Li...
JERSEY, Channel Islands, May 31, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive O...
JERSEY, Channel Islands, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...
MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have be...
JERSEY, Channel Islands, May 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fourth quarter and ...
Initial MosaiQ manufacturing system commissioned and validatedFirst “commercially ready” MosaiQ Instrument delivered to QuotientInternal validation of MosaiQ underway, with EU field trials expe...
Performance evaluation studies confirm required concordance levels for all assaysVerification and validation studies to commence shortly European field trials still expected to be completed in CY17...
Famotidine Tablets, USP 20 mg
Facility Maintenance Instant Hand Sanitizer HS-67
Amar ICE GEL
ChondroGene is a genomics-based company focused on the discovery and development of disease-specific therapeutic and diagnostic approaches, specializing in osteoarthritis. The Company has constructed ...
Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...
ChondroGene was formed in 1998 with the bringing together of its two key founders; Dr. K. Wayne Marshall, a noted orthopaedic surgeon and knee specialist and Dr. C.C. Liew, an internationally recogniz...
Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...
We have published hundreds of ChondroGene Limited news stories on BioPortfolio along with dozens of ChondroGene Limited Clinical Trials and PubMed Articles about ChondroGene Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ChondroGene Limited Companies in our database. You can also find out about relevant ChondroGene Limited Drugs and Medications on this site too.
Arthritis is by definition the inflammation of one or more joints, characterized by swelling, pain, warmth, redness and diminished range of joint movement (Oxford Medical Dictionary). There are many different types; Noninflammatory; Osteoarthritis, N...
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...